Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer

[1]  M. Urken,et al.  Pathologic Reporting of Lymph Node Metastases in Differentiated Thyroid Cancer: a Call to Action for the College of American Pathologists , 2014, Endocrine Pathology.

[2]  Stephanie L. Lee,et al.  Management of recurrent and persistent metastatic lymph nodes in well‐differentiated thyroid cancer: A multifactorial decision‐making guide for the thyroid cancer care collaborative , 2014, Head & neck.

[3]  M. Urken,et al.  American Thyroid Association statement on outpatient thyroidectomy. , 2013, Thyroid : official journal of the American Thyroid Association.

[4]  E. Pribitkin,et al.  Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer? , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[5]  Samuel L. Oyer,et al.  Reevaluating the Prognostic Significance of Age in Differentiated Thyroid Cancer , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[6]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[7]  M. Haymart.  Understanding the relationship between age and thyroid cancer. , 2009, The oncologist.

[8]  J. Shah.  Re: Extent of surgery affects papillary thyroid cancer. , 2008, Annals of surgery.

[9]  I. Sugitani,et al.  A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. , 2004, Surgery.

[10]  B. Cady.  Presidential address: beyond risk groups--a new look at differentiated thyroid cancer. , 1998, Surgery.

[11]  P. Ladenson,et al.  Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. , 1998, Cancer.

[12]  P. Ladenson,et al.  Prospective multicenter study of thyroid carcinoma treatment , 1998 .

[13]  S. Sherman.  Staging of thyroid carcinoma‐reply , 1998, Cancer.

[14]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[15]  C. Begg,et al.  Prognostic factors in differentiated carcinoma of the thyroid gland. , 1992, American journal of surgery.

[16]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.

[17]  G. Randolph,et al.  Surgery of the Thyroid and Parathyroid Glands , 1984 .

[18]  M. van Glabbeke,et al.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. , 1979, European journal of cancer.

[19]  J. Shah,et al.  Changing trends in well differentiated thyroid carcinoma over eight decades. , 2012, International journal of surgery.

[20]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.